Related references
Note: Only part of the references are listed.Inflammatory Cytokine-Induced Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1 in Mesenchymal Stem Cells Are Critical for Immunosuppression
Guangwen Ren et al.
JOURNAL OF IMMUNOLOGY (2010)
The degree of myelosuppression during maintenance therapy of adolescents with B-lineage intermediate risk acute lymphoblastic leukemia predicts risk of relapse
K. Schmiegelow et al.
LEUKEMIA (2010)
Antitumor activity of cytokine-induced killer cells in nude mouse xenograft model
Hwan Mook Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2009)
Cytokine induced killer cells as adoptive immunotherapy strategy to augment graft versus tumor after hematopoietic cell transplantation
D. Sangiolo et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Immunotherapy with cytokine induced killer cells in solid and hematopoietic tumours: a pilot clinical trial
Paola Olioso et al.
HEMATOLOGICAL ONCOLOGY (2009)
A Case of Natural Killer Cell Leukemia Misdiagnosed as Tuberculous Lymphadenopathy
A-jin Lee et al.
KOREAN JOURNAL OF LABORATORY MEDICINE (2009)
Infections in Pediatric Patients With Hematologic Malignancies
L. Charles Bailey et al.
SEMINARS IN HEMATOLOGY (2009)
HLA-G is a Crucial Immunosuppressive Molecule Secreted by Adult Human Mesenchymal Stem Cells
Zohair Selmani et al.
TRANSPLANTATION (2009)
The Immunosuppressive Properties of Mesenchymal Stem Cells
Georg Siegel et al.
TRANSPLANTATION (2009)
Mesenchymal Stem Cells Require a Sufficient, Ongoing Immune Response to Exert Their Immunosuppressive Function
P. Renner et al.
TRANSPLANTATION PROCEEDINGS (2009)
Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification
Soraya Carrancio et al.
EXPERIMENTAL HEMATOLOGY (2008)
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease:: a phase II study
Katarina LeBlanc et al.
LANCET (2008)
Bioluminescence imaging to monitor the in vivo distribution of administered mesenchymal stem cells in acute kidney injury
Florian Toegel et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Manufacture of a human mesenchymal stem cell population using an automated cell culture platform
Robert James Thomas et al.
CYTOTECHNOLOGY (2007)
Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subclone
Seoyeon Choi et al.
BLOOD (2007)
Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I study
Martino Introna et al.
HAEMATOLOGICA (2007)
Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling
Jacqueline D. Shields et al.
CANCER CELL (2007)
Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells:: impact on in vivo tumor growth
R. Ramasamy et al.
LEUKEMIA (2007)
Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation
GM Spaggiari et al.
BLOOD (2006)
Bone marrow stem cells as a vehicle for delivery of heme oxygenase-1 gene
HL Zhou et al.
STEM CELLS AND DEVELOPMENT (2006)
Donor cell cycling, trafficking, and accumulation during adoptive immunotherapy for murine lung metastases
J Skitzki et al.
CANCER RESEARCH (2004)
Bone marrow-derived mesenchymal stem cells already express specific neural proteins before any differentiation
T Tondreau et al.
DIFFERENTIATION (2004)
Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis
N Nagaya et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Effects of peripheral benzodiazepine receptor ligands on proliferation and differentiation of human mesenchymal stem cells
DH Lee et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2004)
Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia:: evidence for the persistence of a preleukemic clone
M Konrad et al.
BLOOD (2003)
Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates
SM Devine et al.
BLOOD (2003)
Generation of CD3+CD56+ cytokine-induced killer cells and their in vitro cytotoxicity against pediatric cancer
S Hongeng et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2003)
Distribution of adoptively transferred, tumor-sensitized lymphocytes in the glioma-bearing rat
MR Hazelrigg et al.
JOURNAL OF NEURO-ONCOLOGY (2002)
Xenotransplant cardiac chimera: Immune tolerance of adult stem cells
T Saito et al.
ANNALS OF THORACIC SURGERY (2002)
Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo
A Bartholomew et al.
EXPERIMENTAL HEMATOLOGY (2002)
Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion
SM Devine et al.
EXPERIMENTAL HEMATOLOGY (2001)
Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep
KW Liechty et al.
NATURE MEDICINE (2000)
Nonhematopoietic mesenchymal stem cells: what are they?
EM Horwitz et al.
CYTOTHERAPY (2000)
Share Paper
